Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2004, Vol. 2 ›› Issue (3): 231-234.doi: 10.3736/jcim20040327

• Lecture • Previous Articles     Next Articles

Discussion on clinical efficacy of Hypericum perforatum for depression abroad

De-po Yang, Liang-chun Gan, Hai-yan Hu   

  1. Laboratory of Pharmacognosy and Natural Medicinal Chemistry, School of Pharmacy, Sun Yat-Sen University, Guangzhou, Guangdong Province 510275, China
  • Online:2004-06-20 Published:2018-10-25

The development of molecular pharmacology and neuropharmacology accelerated the studies on molecular mechanism of Hypericum perforatum for depression. The clinical trials indicated that this galenical was superior to the traditional synthetic drugs for antidepression. This preparation had good tolerability and safety. Clinical pharmacokinetics and pharmacodynamics provided further evidence for clinical application of Hypericum. The clinical efficacy of Hypericum for depression was notable and credible.

Key words: Hypericum perforatum, antidepression, drug evaluation

CLC Number: 

  • R286.1
[1] ESCOP.Hyperici herba" monographs on the medicinal uses of plant drugs(1st ed)[M].Exeter, U.K: European Scientific Cooperative on Phytotherapy,1997, 1997,(1st ed):
[2] Kleber E, Obry T, Hippeli S , et al. Biochemical activities of extracts from Hypericum perforatum L. 1st communication: inhibition of dopamine-beta-hydroxylase[J]. Arzneimittelforschung, 1999,49(2):106-109
[3] Thiede HM, Walper A . Inhibition of MAO and COMT by hypericum extracts and hypericin[J]. Psychiatry Neurol, 1994,7(Suppl 1):S54-S56
doi: 10.1177/089198879400700114 pmid: 7857510
[4] Denke A, Schneider W, Elstner EF . Biochemical activities of extracts from Hypericum perforatum L. 2nd communication: inhibition of metenkephaline- and tyrosine-dimerization[J]. Arzneimittelforschung, 1999,49(2):109-114
[5] Chatterjee SS, Bhattacharya SK, Wonnemann M , et al. Hyperforin as a possible antidepressant component of hypericum extracts[J]. Life Sci, 1998,63(6):499-510
doi: 10.1016/S0024-3205(98)00299-9 pmid: 9718074
[6] Laakmann G, Jahn G, Schule C . Hypericum perforatum extract in treatment of mild to moderate depression. Clinical and pharmacological aspects[J]. Nervenarzt, 2002,73(7):600-612
doi: 10.1007/s00115-002-1300-9
[7] Jensen AG, Hansen SH, Nielsen E . Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity[J]. Life Sci, 2001,68(14):1593-1605
[8] Linde K, Ramirez G, Mulrow CD , et al. St Johns wort for depression--an overview and meta-analysis of randomised clinical trials[J]. BMJ, 1996,313(7052):253-258
doi: 10.1136/bmj.313.7052.253 pmid: 8704532
[9] Volz HP . Controlled clinical trials of Hypericum extracts in depressed patients--an overview[J]. Pharmacopsychiatry, 1997,30(Suppl 2):72-76
doi: 10.1055/s-2007-979522 pmid: 9342763
[10] Laakmann G, Schule C, Baghai T , et al. St. Johns wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy[J]. Pharmacopsychiatry, 1998,31(Suppl 1):54-59
[11] Wheatley D . LI 160, an extract of St. Johns wort, versus amitripyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial[J]. Pharmacopsychiatry, 1997,30(Suppl 2):77-80
[12] Vorbach EU, Arnoldt KH, Hubner WD . Efficacy and tolerability of St. Johns wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10[J]. Pharmcopsychiatry, 1997,30(Suppl 2):81-85
[13] Schrader E, Meier B, Brattstrom A . Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre study[J]. Hum Psychopharmacol, 1998,13(3):163-169
[14] Phillip M, Kohnen R, Hiller KO . Hypericum extract versus imipramine or placebo in patients with moderate depression: randomized multicentre study of treatment for eight weeks[J]. BMJ, 1999,319(7224):1534-1539
[15] Harrer G, Schmidt U, Kuhn U , et al. Comparison of equivalence between the St. Johns wort extract LoHyp-57 and fluoxetine[J]. Arzneimittelforschung, 1999,49(4):289-296
doi: 10.1055/s-0031-1300417 pmid: 10337446
[16] Schrader E . Equivalence of St. Johns wort extract(Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression[J]. Int Clin Psychopharmacol, 2000,15(2):61-68
[17] Brenner R, Azbel V, Madhusoodanan S , et al. Comparison of an extract of hypericum(LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study[J]. Clin Ther, 2000,22(4):411-419
[18] van Gurp G, Meterissian GB, Haiek LN , et al.St Johns wort or sertraline? Randomized controlled trial in primary care[J].Can Fam Physician, 2002, 48 905-912
pmid: 12053635
[19] Lecrubier Y, Clerc G, Didi R , et al. Efficacy of St Johns wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial[J]. Am J Psychiatry, 2002,159(8):1361-1366
[20] Shelton RC, Keller MB, Gelemberg A , et al. Effectiveness of St Johns wort in major depression: a randomized controlled trial[J]. JAMA, 2001,285(15):1978-1986
[21] Ernst E, Rand J, Barnes J , et al. Adverse effects profile of the herbal antidepressant St Johns wort(Hypercicum perforatum L.)[J]. Eur J Clin Pharmacol, 1998,54(8):589-594
[22] Stevinson C, Ernst E . Hypericum for depression. An update of the clinical evidence[J]. Eur Neuropsychopharmacol, 1999,9(6):515-505
doi: 10.1016/S0924-977X(99)00032-2 pmid: 10625118
[23] Whiskey E, Werneke U, Taylor D . A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review[J]. Int Clin Psychopharmacol, 2001,16(5):239-252
[24] Woelk H, Burkard G , Grn wald J.Benefits and risks of the Hypericum extract LI 160: drug monitoring study with 3250 patients[J]. J Geriatr Psychiatry Neurol, 1994,7(suppl 1):S34-S38
[25] Goldman RD, Koren G, Motherisk T , .aking St Johns wort during pregnancy[J].Can Fam Physician, 2003, 49 29-30
[26] Lee A, Minhas R, Matsuda N , et al. The safety of St Johns wort(Hypericum perforatum) during breastfeeding[J]. J Clin Psychiatry, 2003,64(8):966-968
[27] Brockmoller J, Reum T, Bauer S , et al. Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans[J]. Pharmacopsychiatry, 1997,30(Suppl 2):94-101
doi: 10.1055/s-2007-979527 pmid: 9342768
[28] Schempp CM, Winghofer B, Langheinrich M , et al. Hypericin levels in human serum and interstitial skin blister fluid after oral single-dose and steady-state administration of Hypericum perforatum extract(St Johns wort)[J]. Skin Pharmacol Appl Skin Physiol, 1999,12(5):299-304
[29] Nebel A, Schneider BJ, Baker RK , et al. Potential metabolic interaction between St Johns wort and theophylline[J]. Ann Pharmacother, 1999,33(4):502
doi: 10.1345/aph.18252 pmid: 10332544
[30] Markowitz JS, Donovan JL, Devane CL , et al. Effect of St Johns wort on drug metabolism by induction of cytochrome P450 3A4 enzyme[J]. JAMA, 2003,290(11):1500-1504
[31] Johne A, Brockmoller J, Bauer S , et al. Pharmacokinetic interaction of digoxin with an herbal extract from St Johns wort(Hypericum perforatum)[J]. Clin Pharmcol Ther, 1999,66(4):338-345
[32] Roby CA, Anderson GD, Kantor E , et al. St Johns wort: effect on CYP3A4 activity[J]. Clin Pharmacol Ther, 2000,67(5):451-457
doi: 10.1067/mcp.2000.106793 pmid: 10824623
[33] Piscitelli SC, Burstein AH, Chaitt D , et al. Indinavir concentrations and St Johns wort[J]. Lancet, 2000,355(9203):547-548
doi: 10.1016/S0140-6736(99)05712-8 pmid: 10683007
[34] de Maat MM, Hoetelmans RM, Mathot RA , et al. Drug interaction between St Johns wort and nevirapine[J]. AIDS, 2001,15(3):420-421
doi: 10.1097/00002030-200102160-00019 pmid: 11273226
[35] Yue QY, Bergquist C, Gerden B . Safety fo St Johns wort(Hypericum perforatum)[J]. Lancet, 2000,355(9203):576-577
doi: 10.1016/S0140-6736(05)73225-6 pmid: 10683028
[36] Markowitz JS, DeVane CL, Boulton DW, . et al.Effect of St.Johns wort(Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers[J].Life Sci, 2000, 66(9):PL133-139
[37] Biber A, Fisher H, Romer A , et al. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers[J]. Pharmacopsychiatry, 1998,31(Suppl 1):36-43
doi: 10.1055/s-2007-979344 pmid: 9684946
[38] Klier CM, Schafer MR, Schmid-Siegel B , et al. St. Johns wort(Hypericum perforatum) - - is it safe during breastfeeding?[J]. Pharmacopsychiatry, 2002,35(1):29-30
[39] Bennett DA, Phun L, Polk JF , et al. Neuropharmacology of St. John's wort(Hypericum)[J]. Ann Pharmacother, 1998,32(11):1201-1208
doi: 10.1345/aph.18026 pmid: 9825087
[1] Jie-ning Wang, Sheng Ye, Dong-hai Yu, Hui Zhao, Le-yi Du. Practice and exploration on clinical evaluations of hospital-made Chinese herbal formulas in the Pudong New Area of Shanghai. Journal of Chinese Integrative Medicine, 2012, 10(10): 1084-1087.
[2] Feng Tian , Yan-ming Xie. Real-world study: A potential new approach to effectiveness evaluation of traditional Chinese medicine interventions. Journal of Chinese Integrative Medicine, 2010, 8(4): 301-306.
[3] Hong-cai Shang, Bo-li Zhang, You-ping Li. Clinical orientation of post-marketing Chinese patent drugs: an evidence-based practice. Journal of Chinese Integrative Medicine, 2008, 6(9): 887-890.
[4] Feng-lan Zhu​, Chao Gu​, Zhi-feng Zhang​, Chang-le Zhou​, Jia-tuo Xu​, Xiao-gu Liu​, Wen-shu Li​, Hui-qing Zhu​. Evaluation of therapeutic effects of Chinese materia medica by tongue image analysis software 1.0 based on tongue colors. Journal of Chinese Integrative Medicine, 2006, 4(2): 152-155.
Full text



[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239